CoChat

Randomized Trial of 2‐Dose versus Monthly Sulfadoxine‐Pyrimethamine Intermittent Preventive Treatment for Malaria in HIV‐Positive and HIV‐Negative Pregnant Women in Malawi

Filler, Scott J., Kazembe, Peter, Thigpen, Michael, Macheso, Alan, Parise, Monica E., Newman, Robert D., Steketee, Richard W., Hamel, Mary · 2006 · The Journal of Infectious Diseases

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) decreases placental malaria parasitemia and associated maternal anemia, premature delivery, and low birth weight. However, the optimal regimen in the setting of a high prevalence of human immunodeficiency virus (HIV) infection remains unclear. METHODS: In Malawi, where the efficacy of SP for the treatment of malaria in children is decreasing, we conducted a randomized, nonblinded study to compare the efficacy of monthly SP IPTp with a 2-dose regimen for the prevention of placental parasitemia in HIV-positive and -negative primigravid and secundigravid women. RESULTS: Of HIV-positive women, 7.8% who received monthly SP had placental malaria, compared with 21.5% of those who received 2-dose SP (relative risk [RR], 0.36 [95% confidence interval {CI}, 0.17-0.79]). Of HIV-negative women, 2.3% who received monthly SP and 6.3% who received 2-dose SP had placental malaria (RR, 0.37 [95% CI, 0.11-1.19]). Less than 1% of women reported adverse drug reactions, with no increase in HIV-positive women or those who received monthly SP. CONCLUSIONS: In HIV-positive pregnant women, monthly SP IPTp is more efficacious than a 2-dose regimen in preventing placental malaria. The study also demonstrates the continued efficacy of SP for the prevention of placental malaria, even in the face of its decreasing efficacy for the treatment of malaria in children. In areas with intense transmission of falciparum malaria and a high prevalence of HIV infection, monthly SP IPTp should be adopted.

Overview

Integrity signals

Registry

Crossref · 10.1086/505080

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 122

Metadata

Authors
Filler, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., Steketee, R. W., & Hamel, M.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Ministry of Health (MW)
Venue
The Journal of Infectious Diseases
Published
2006-08
Volume
194
Issue
3
Pages
286-293
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2117002844
Cited by
108
References
25
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 13 · 2012: 8
FWCI
11.32
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
Keywords
sulfadoxine-pyrimethamine, placental malaria, HIV-positive pregnant women, dosing regimen comparison, falciparum malaria, antimalarial drug efficacy, adverse drug reactions, Malawi
MeSH terms
Adolescent, Adult, Antimalarials, Drug Administration Schedule, Drug Combinations, Female, Humans, Infant, Newborn, Malawi, Pregnancy, Pregnancy Complications, Infectious, Pyrimethamine, Sulfadoxine, Pregnancy Complications, Parasitic, HIV Infections, Trimethoprim, Sulfamethoxazole Drug Combination, Malaria, Falciparum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial of 2‐Dose versus Monthly Sulfadoxine‐Pyrimethamine Intermittent Preventive Treatment for Malaria in HIV‐Positive and HIV‐Negative Pregnant Women in Malawi. https://app.cochat.ai/papers/10.1086/505080
The paper
Filler, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., Steketee, R. W., & Hamel, M. (2006). Randomized Trial of 2‐Dose versus Monthly Sulfadoxine‐Pyrimethamine Intermittent Preventive Treatment for Malaria in HIV‐Positive and HIV‐Negative Pregnant Women in Malawi. The Journal of Infectious Diseases. https://doi.org/10.1086/505080

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.